PRODUCT DETAIL

Everolimus Pharmagen 10 mg tablety

Code

2762E

MA number

44/0034/23-S

Product Form:

tbl 90x10 mg (blis.Al/PA/Al/PVC)

MA Status:

R - Valid Marketing Authorisation

Type of procedure:

Decentralised

Therapeutic Class:

44 - CYTOSTATICA

ATC:

L	ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L01	ANTINEOPLASTIC AGENTS
L01E	Protein kinase inhibitors
L01EG	Mammalian target of rapamycin (mTOR) kinase inhibitors
L01EG02	Everolimus

Shelf life:

Route of admin.:

Oral use

Prescription Status:	Medicinal product subject to restricted medical prescription.
Legal basis:	Article 10(1) generic application
MA issued:	31.01.2023
Validity:	31.01.2028
SPC:	SPC_Everolimus Pharmagen 10 mg tablety_06.2023.pdf
PIL:	PIL_Everolimus Pharmagen 10 mg tablety_06.2023.pdf
Safety feature	Yes
Data update:	14.02.2023